Naloxone – FDA hosts meeting to discuss expanded use of overdose medicine

Naloxone – FDA hosts meeting to discuss expanded use of overdose medicine

Naloxone – FDA hosts meeting to discuss expanded use of overdose medicine

By: Peter Lurie, M.D., M.P.H.

At the FDA, we’re proud of our work supporting the development of important and innovative medical products that address the critical needs of patients. Sometimes this means wholly new molecules to treat previously untreatable diseases; … Continue reading →